Press Releases

ProMed Pharma announces the initiation of a preclinical rat study to assess the pharmacokinetics of a novel resorbable long-acting contraceptive implant ProMed Pharma is pleased to announce the initiation of...

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property April Plymouth MN SpineThera Inc a privately held clinical-stage pharmaceutical company focused on the development of SX...

ProMed Pharma Celebrates -year Anniversary of New Maple Grove Development and Analytical Laboratories ProMed Pharma recently celebrated the one-year anniversary of the opening of its New Product Development and Analytical...